e-learning
resources
Vienna 2012
Saturday, 01.09.2012
PG13 AirPROM: patient-specific modelling and systems biology living labs workshop
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The need and potential of patient-specific modelling
C. Brightling (Leicester, United Kingdom)
Source:
Annual Congress 2012 - PG13 AirPROM: patient-specific modelling and systems biology living labs workshop
Session:
PG13 AirPROM: patient-specific modelling and systems biology living labs workshop
Session type:
Postgraduate Course
Number:
125
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Brightling (Leicester, United Kingdom). The need and potential of patient-specific modelling. Annual Congress 2012 - PG13 AirPROM: patient-specific modelling and systems biology living labs workshop
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
The potential of modelling
Source: International Congress 2014 – AirPROM: can imaging and modelling take us beyond FEV1?
Year: 2014
Leveraging causal modeling to predict future COPD
Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD
Year: 2021
The evaluation of frequency dependence of resistance using a patient-specific 3D physical model and a computational model
Source: International Congress 2017 – Lung function testing in different patient categories
Year: 2017
Which modelling methodology is best?
Source: ERS Research Seminar 2017 – The impact of air pollution on respiratory health
Year: 2018
Halotherapy and Covid-19: an oppinion for a possible future prevention approach
Source: Virtual Congress 2021 – COVID – 19: treatments and predictive factors
Year: 2021
Features of asthma management: quantifying the patient‘s perspective using discrete choice modelling
Source: Eur Respir J 2006; 28: Suppl. 50, 122s
Year: 2006
Applying new respiratory function technologies to the elderly and the potential of future lung regeneration
Source: Virtual Congress 2020 – Lung health and respiratory function at all ages
Year: 2020
Developing a novel
in vitro
3D airway model to provide a viable alternative to animal use in asthma research
Source: Annual Congress 2012 - Cell culture and animal models of lung disease
Year: 2012
What regulatory framework is preferable for successful harm reduction?
Source: Research Seminar 2005 - Tobacco Smoking: Harm Reduction Strategies
Year: 2005
There is no rationale to still rely on outdated, biased tools for quantitative morphology in pulmonary research
Source: Eur Respir Rev 2006; 15: 105-106
Year: 2006
Methodological approach to the development of a learning needs assessment tool
Source: International Congress 2018 – Acutely hospitalised patients: physiotherapy interventions and assessment methods
Year: 2018
Individualised field testing is a useful tool to evaluate difficult asthma.
Source: International Congress 2017 – Diagnostic tools and comorbidities in paediatric asthma
Year: 2017
HOPE-BAL: A novel tool to expand the methodological capabilities in pulmonary research
Source: Annual Congress 2012 - New results in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease
Year: 2012
What do we need in the clinic and what approach can clinicians take to improve the drug development pipeline?
Source: ERS Research Seminar 2016
Year: 2016
Genetic studies as a tool for identifying novel potential targets for treatment of COPD
Source: Eur Respir J, 50 (5) 1702042; 10.1183/13993003.02042-2017
Year: 2017
Do we need a gender-specific approach for health interventions?
Source: Virtual Congress 2021 – Highlights on gender and respiratory health
Year: 2021
Pathophysiology and potential future therapeutic targets using preclinical models of COVID-19
Source: ERJ Open Res, 6 (4) 00405-2020; 10.1183/23120541.00405-2020
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept